Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-04-27 Conversion | 2021-04-29 9:10 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 39,725,922 | $0 | 349,674 (Indirect) | View |
2021-04-27 Conversion | 2021-04-29 9:10 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 101,456 | $13.5 | 349,674 (Indirect) | View |
2021-04-22 Other | 2021-04-26 6:24 pm | N/A 2021-12-31 | IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 1,359,799 | $0 | 1,359,799 (Indirect) | View |
Ownership | 2021-04-22 9:30 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 0 | $0 | 2,208,333 (Indirect) | View |
2021-02-09 Exercise | 2021-02-09 3:37 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner | 64,319 | $0.07 | 150,000 (Indirect) | View |
2021-02-09 Conversion | 2021-02-09 3:37 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner | 3,414,343 | $0 | 150,000 (Indirect) | View |
2021-02-09 Exercise | 2021-02-09 3:37 pm | N/A 2028-07-26 | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner | 64,319 | $0 | 150,000 (Indirect) | View |
2021-02-09 Conversion | 2021-02-09 3:08 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 3,426,240 | $0 | 357,353 (Indirect) | View |
Ownership | 2021-02-04 7:33 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC 10% Owner | 0 | $0 | 3,521,517 (Indirect) | View |
Ownership | 2021-02-04 5:05 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 0 | $0 | 2,200,133 (Indirect) | View |
2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2,997,030 | $0 | 430,372 (Indirect) | View |
Ownership | 2020-10-15 5:17 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 0 | $0 | 2,997,030 (Indirect) | View |